PLX
Protalix BiotherapeuticsANYSE American / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
Current thesis
The post-earnings company update is better than the prior baseline because Protalix reaffirmed full-year revenue guidance, reported a materially stronger cash position, and kept PRX-115 enrollment on track. Secondary market sources also indicated the quarter beat consensus on EPS and revenue, though exact low-coverage consensus figures were inconsistent across checked aggregators.
Posture
Constructive
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite.
What can break
Commercial revenue remains concentrated in partners and can be distorted by ordering cadence, especially Pfizer and Chiesi timing.
Momentum
98
Value
52
Sentiment
58
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $2.20 · Bull $3.20 · Bear $1.10
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-06-01 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-16 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-06-02
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade A · Constructive
Confidence Medium · Net Neutral
Target $12.00
Why
Momentum98 · Δ7d -
Value52 · Δ7d +0.3
Sentiment58 · Δ7d -
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Momentum · See technicals
Momentum
98
34% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
52
32% active weight
Current posture
7d trendFlat
Δ7d
+0.3
Δ21d
+0.1
Sentiment
58
33% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade A. Momentum 98.3 / Value 52.0 / Sentiment 58.2
Fundamentals (TTM)As of 2026-06-01
Fundamentals (TTM)
As of 2026-06-01
Market Cap
$165.98M
Beta
-0.21
Shares Out
80.42M
P/E (TTM)
38.8
P/S (TTM)
2.33
P/FCF (TTM)
19.47
Rev YoY
-0.6%
EPS YoY
-26.9%
Gross Margin
+57.5%
Op Margin
+10.3%
Net Debt
-$34.83M
Current Ratio
3.03
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology